Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
about
The HIV glycan shield as a target for broadly neutralizing antibodiesNative functionality and therapeutic targeting of arenaviral glycoproteinsCell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 EnvelopeComposition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope GlycoproteinHIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Carboxybetaine Modified Interface for Electrochemical Glycoprofiling of Antibodies Isolated from Human Serum.Bovine Herpesvirus 4 Modulates Its β-1,6-N-Acetylglucosaminyltransferase Activity through Alternative SplicingRoles of glycans in interactions between gp120 and HIV broadly neutralizing antibodiesMechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodiesTravelling-wave ion mobility and negative ion fragmentation of high-mannose N-glycans.The sense behind retroviral anti-sense transcription.Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.Viral O-GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins.Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities.Towards the next generation of biomedicines by site-selective conjugation.Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.Site-specific glycosylation of the Newcastle disease virus haemagglutinin-neuraminidase.Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.Structural principles controlling HIV envelope glycosylation.Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1.Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer.The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans.Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry.Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.Coupling of Single Molecule, Long Read Sequencing with IMGT/HighV-QUEST Analysis Expedites Identification of SIV gp140-Specific Antibodies from scFv Phage Display Libraries.Isomer Information from Ion Mobility Separation of High-Mannose Glycan Fragments.Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers
P2860
Q26786540-0B336F13-4B94-4DC1-AD9A-44EEBD40EBB2Q26827679-4DD71CAB-94FA-4DDB-9BA4-371877E3698CQ28263655-EFE807C4-5935-4401-9F5E-00834AF753D4Q29306052-14589EFD-AA8A-4532-B6B1-0138D17CD84AQ30393763-0F1D7F40-3687-42B5-AED5-167E398A1A45Q35654967-D1F1F847-A969-423D-AA75-9E68E7F3FCD9Q36524008-7A31B2A5-F087-4420-A9D1-7A2CE98C1541Q36530740-CB102352-91BD-4A70-A549-7C4F6618FB9FQ36531018-BED212D4-5FAB-45EF-827B-64CFF10EBB64Q36767085-43D29549-7974-497A-ADC2-3E6CC66BD6D9Q37587125-4F95C79D-8C1D-42B7-AEFD-7826A8A24EEEQ38290294-A4DE9A73-4FE9-4B5C-9AA6-D570B0FDE5DBQ38622432-FB25C7C3-5F7B-46E0-BDDC-95749C75FD46Q38695294-CB17196F-7CCA-472E-BD96-58988F907FCFQ38706553-A819DBDF-653C-4F5B-82CD-80F11F2DD6B5Q38753943-E2CF6FB2-9FDA-4F77-8847-A9E5553BF470Q38785894-7599686D-3C6D-4D0B-8633-750F037F117FQ38992744-E2EC29EE-76BB-4BF6-8E12-3D9842F6D61AQ39211319-4105B5BF-8F5C-4819-BA16-139A26D95E03Q40058876-99699A09-E0B6-4D70-A7F1-50B5471D623FQ40061438-EB152704-3780-4A9A-937D-50A001F5F278Q40231057-15525F37-30D4-401B-8F5C-FB87080B8D1DQ40406623-B45CFF4C-1C39-4525-8680-42C6FD62EB76Q41924154-2A9D1FF2-ACCE-4E0D-BFD2-D0998302EB9CQ50116524-E62BB31E-4497-4BCF-AC88-65E8D84630E3Q52653118-F4A3862D-37B6-48EB-9F9E-F84F9C117E3EQ52728652-C1098454-F7C6-40DD-A677-EF443C2E82D6Q58721980-7C1223DA-1251-4673-960E-783B61BCDA12
P2860
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@ast
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@en
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@nl
type
label
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@ast
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@en
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@nl
prefLabel
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@ast
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@en
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@nl
P2860
P3181
P1476
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
@en
P2093
Katie J Doores
Max Crispin
P2860
P3181
P356
10.1016/J.COVIRO.2015.02.002
P407
P577
2015-04-01T00:00:00Z